Cost of Illness Type 2 Diabetes Mellitus Outpatient BPJS on Malang City Health Center
Downloads
Background: Type 2 diabetes mellitus is a progressive illness that impacts the costs borne by patients. The Cost of Illness method can be used further to analyze the medical expenses for type 2 diabetes mellitus. Objective: Determine the annual total cost of type 2 diabetes mellitus outpatients in Indonesia Health Insurance (BPJS) participants and treated with metformin-glibenclamide. Methods: This study applied the non-probability sampling technique and the purposive sampling method to the cross-sectional approach. The research was conducted in the Mulyorejo Health Care of Malang City, using 58 patients as samples. The research instrument involves a systematic interview that has been tested for its validity. The data were analyzed using Microsoft Excel. Results: The direct medical cost per patient is IDR 173,560.00 – IDR 1,266,240.00. Non-medical direct cost is IDR 0.00 – IDR 240,000,00. The indirect cost is IDR 0.00 – IDR 1,920.000,00. Conclusion: The estimated annual total medical expenses of diabetes mellitus type 2 Indonesia Health Insurance (BPJS) outpatients employing metformin-glibenclamide therapy at Mulyorejo Health Center in Malang is IDR 173,560.00 – IDR 3,426,240.00.
Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J. & Billah B. (2018). Cost-of-Illness of Type 2 Diabetes Mellitus in Low and Lower-Middle Income Countries: a systematic review. BMC Health Services Research; 18; 1–10. doi: 10.1136/bmjgh-2018-001258.
American Diabetes Association. (2017). Classification and Diagnosis of Diabetes. Diabetes Care; 40; S11–S24.
Baroroh, F., Solikah, W. Y. & Urfiyya, Q. A. (2016). Analisis Biaya Terapi Diabetes Melitus Tipe 2 di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta. Jurnal Farmasi Sains dan Praktis; I; 11–22. doi: 10.31603/pharmacy.v1i2.230.
Darmawan, E., Putri, R. E. K. & Perwitasari, D. A. (2019). Cost of Illness Diabetes Melitus Tipe 2 dan Komplikasinya pada Peserta Jaminan Kesehatan Nasional (JKN) di Rawat Jalan Rumah Sakit Condong Catur Yogyakarta. Jurnal Farmasi Indonesia; 16; 89–101. doi: 10.23917/pharmacon.v16i2.8915.
International Diabetes Federation. (2019). IDF Diabetes Atlas Ninth Edition. https://diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html. Accessed: 23 October 2020.
Kementrian Kesehatan Republik Indonesia. (2018). Hasil Utama Riset Kesehata Dasar (RISKESDAS) 2018. https://kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf. Accessed: 23 October 2020.
Lebbe, S. M. A. & Rinosha, K. F. (2018). Economic Cost of Diabetes in Ampara District in Sri Lanka. Journal of Politics and Law; 11; 146. doi: 10.5539/jpl.v11n4p146.
Lesmana, T. C. & Sugiman. (2020). Determinan Pemilihan Kelas BPJS Peserta Jaminan Kesehatan Nasional Mandiri. Jurnal Endurance: Kajian Ilmiah Problema Kesehatan; 5; 216–226. doi: 10.22216/jen.v5i2.4979.
Masturoh, I. & Anggita, T. N. (2018). Metodologi Penelitian Kesehatan. http://bppsdmk.kemkes.go.id/pusdiksdmk/wp-content/uploads/2018/09/Metodologi-Penelitian-Kesehatan_SC.pdf. Accessed: 23 October 2020.
Mursalin & Soewondo, P. (2017). Analisis Estimasi Biaya Langsung Medis Penderita Rawat Jalan Diabetes Mellitus Tipe 2 di RSUD Dr. Abdul Aziz Singkawang Tahun 2013. Jurnal Ekonomi Kesehatan Indonesia; 1; 5–15. doi: 10.7454/eki.v1i2.1770.
Musdalifah & Nugroho, P. S. (2020). Hubungan Jenis Kelamin dan Tingkat Ekonomi dengan Kejadian Diabetes Melitus di Wilayah Kerja Puskesmas Palaran Kota Samarinda Tahun 2019. Borneo Student Research; 1; 1238–1242.
Nur, R. A., Ab, I. & Setyowati, D. L. (2018). Analisis Fator yang Mempengaruhi Pemilihan Kelas Kepesertaan Jaminan Kesehatan Nasional. Faletehan Health Journal; 5; 135-141. doi: 10.33746/fhj.v5i3.32.
PERKENI. (2019). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2019. https://pbperkeni.or.id/wp-content/uploads/2020/07/Pedoman-Pengelolaan-DM-Tipe-2-Dewasa-di-Indonesia-eBook-PDF-1.pdf. Accessed: 23 October 2020.
Punthakee, Z., Goldenberg, R. & Katz, P. (2018). Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Canadian Journal of Diabetes; 42; S10–S15. doi: 10.1016/j.jcjd.2017.10.003.
Rantung, J., Yetti, K. & Herawati, T. (2015). Hubungan Self-Care dengan Kualitas Hidup Pasien Diabetes Mellitus (DM) di Persatuan Diabetes Indonesia (PERSADIA) Cabang Cimahi. Jurnal Skolastik Keperawatan; 1; 38–51. doi: 10.35974/jsk.v1i01.17.
Rascati, K. L. (2013). Essentials of Pharmacoeconomics: Second Edition (2nd ed). Philadelphia: Wolters Kluwer Health.
Wijaya, I. N., Faturrohmah, A., Agustin, W. W., Soesanto, T. G., Kartika, D. & Prasasti, H. (2015). Profil Kepatuhan Pasien Diabetes Melitus Puskesmas Wilayah Surabaya Timur Dalam Menggunakan Obat Dengan Metode Pill Count. Jurnal Farmasi Komunitas; 2; 18–22.
Copyright (c) 2022 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
